PA
LLY icon

Paragon Advisors’s Eli Lilly LLY Stock Holding History

Paragon Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.57M Sell
4,966
-76
-2% -$77K 1.23% 22
2025
Q4 		$5.42M Buy
5,042
+335
+7% +$320K 1.47% 18
2025
Q3 		$3.59M Sell
4,707
-1,740
-27% -$1.29M 0.93% 32
2025
Q2 		$5.03M Buy
6,447
+78
+1% +$60.6K 1.31% 18
2025
Q1 		$5.26M Sell
6,369
-18
-0.3% -$15K 1.99% 12
2024
Q4 		$4.93M Sell
6,387
-136
-2% -$113K 1.69% 18
2024
Q3 		$5.78M Buy
6,523
+28
+0.4% +$25.2K 1.88% 11
2024
Q2 		$5.88M Buy
6,495
+2,933
+82% +$2.35M 2.14% 11
2024
Q1 		$2.77M Buy
3,562
+1,332
+60% +$948K 1.12% 27
2023
Q4 		$1.3M Buy
2,230
+511
+30% +$298K 0.55% 54
2023
Q3 		$923K Buy
1,719
+133
+8% +$68.5K 0.38% 65
2023
Q2 		$743K Sell
1,586
-2,410
-60% -$1.01M 0.24% 83
2023
Q1 		$1.37M Buy
3,996
+1,413
+55% +$477K 0.46% 54
2022
Q4 		$944K Buy
+2,583
New +$916K 0.42% 55

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Paragon Advisors's LLY Position: Q1 2026 in Review

Paragon Advisors reduced its Eli Lilly (LLY) stake by 1.5% in Q1 2026, selling an estimated $77K and leaving 4,966 shares worth $4.57M. The position accounts for 1.23% of the portfolio, ranked #22.

Paragon Advisors first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $5.88M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Paragon Advisors held 4,966 shares of Eli Lilly worth $4.57M as of Q1 2026.
  • Paragon Advisors sold 76 Eli Lilly shares in Q1 2026, an estimated $77K.
  • Eli Lilly made up 1.23% of Paragon Advisors's portfolio in Q1 2026, its #22 holding.
  • Paragon Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Paragon Advisors's Eli Lilly position peaked at $5.88M in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Paragon Advisors's 13F filing for Q1 2026, filed 4 May 2026.